Attending Biotech and Pharma
Bioregion Partners
Why attend BOS clinical?
• Network with your peers from international biotech & pharma clinical development.
• Exchange ideas and transfer knowledge regarding successful outsourcing.
• Hear from leading authorities in key areas of clinical development outsourcing.
• Organise 1:1 meetings with leading clinical development vendors & industry consultants.
Welcome to the Biotech Outsourcing Strategies (BOS) series of forums devised and managed by Bio2Business Ltd (www.bio2business.com). BOS is the evolution of an ongoing 5 year project by Bio2Business Ltd to facilitate R&D outsourcing and partnering for international biotech and pharmaceutical companies.
A Day of Partnering & Networking
BOS clinical is primarily a partnering event - a forum to connect international clinical development biotech & pharma outsourcing executives with a network of specialist CROs. BOS clinical has a clear focus on clinical development. As a delegate attending BOS in London you can expect to meet with a significant number of high quality international clinical vendors who offer proven, reliable services. You will be able to organise 1 to 1 meetings with CROs, consultants and fellow clinical development executives throughout the day using Bio2Business partnering software. Informal networking over coffee, lunch and closing drinks receptions will give you an ideal opportunity to make links with fellow discovery/development executives and exchange ideas and approaches to outsourcing.
Speaker Programme
In addition to providing a partnering forum for clinical development attendees, BOS also strives to deliver an outstanding programme of speakers to deliver perspective and approaches in the field of drug discovery & development. This year we are pleased to announce a first class programme of speakers including: Dr Sally Waterman, Director of Research & Development, Protherics; Dr Uwe Meya, VP Clinical Research & Development, Synosia Therapeutics; Dr Denis Mir, Clinical Project Manager, Antisoma; Dr Rob Williams, Head of Drug Development Projects & Non Clinical Development, Cancer Research UK; Dr Chris Beattie, Director of Clinical and Regulatory Affairs, Onyvax; Dr Eric Hurden, Associate Director Clinical Operations, Oncology, Biogen Idec.
Our speakers are international experts in their areas of clinical development. We believe such a blend of speakers talking about critical areas of clinical development will give a unique perspective on current approaches to biotech and pharma clinical outsourcing.
Key Sponsors
Gold CRO Sponsors
Silver CRO Sponsor
Exhibition Sponsor
Media Partner
